Aug 06, 2012, 01.34 PM | Source: Moneycontrol.com
Sun Pharmaceutical Industries gained more than 2% intraday on Monday as board members will consider internal restructuring of business on August 10.
The stock has touched a 52-week high of Rs 674.55. At 13:23 hours IST, the share was trading at Rs 668.50, up 1.28% with volumes of 30,216 equity shares.
Market capitalisation of the company currently stands at Rs 69,228.65 crore.
Stay invested in Sun Pharma, says Ashish Kyal
Ashish Kyal of wavesstrategy.com is of the view th
Sun Pharma Advanced Research's Q3 net loss widens to Rs 41 cr
The company had posted a net loss of Rs 18.91 cror
Sun Pharma gains; launches Imatinib Mesylate in US market
The company's subsidiary has received final approv
Sun hopes cut-price generic Gleevec will win third of US market
Gleevec, or imatinib mesylate, costs up to about U
Sun completes sale of 2 Ranbaxy divisions to Strides
Sun Pharma may test Rs 885-900, says Yogesh Mehta
Yogesh Mehta of Motilal Oswal Securities is of the
Aurobindo Pharma Q3 net profit at Rs 534.95 cr
The board of the company has approved third interi
Lupin, Cipla top picks from pharma space: Parag Thakkar
Parag Thakkar, Head of Sales at HDFC Securities is